(Q37982443)

26 August 2017

title

Minimizing toxicity in early-stage testicular cancer treatment (English)

1 reference

26 August 2017

1 reference

Mausam Singhera

1

1 reference

26 August 2017

Kathryn Lees

series ordinal

2

1 reference

26 August 2017

Robert Huddart

series ordinal

3

1 reference

26 August 2017

Alan Horwich

series ordinal

4

1 reference

26 August 2017

publication date

1 February 2012

1 reference

Expert Review of Anticancer Therapy

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

185-193

1 reference

Trends in testicular carcinoma in England and Wales, 1971-99.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Spatial variation and temporal trends of testicular cancer in Great Britain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Mortality after cure of testicular seminoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Increased mortality rates in young and middle-aged patients with malignant germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Noncancer causes of death in survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Mortality and incidence of second cancers following treatment for testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Effect of radiotherapy volume and dose on secondary cancer risk in stage I testicular seminoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Platinum organ toxicity and possible prevention in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Testosterone and ill-health in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Fertility, gonadal and sexual function in survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Paternity following treatment for testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Long-term renal function after treatment for malignant germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Bleomycin-induced pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Pulmonary function in long-term survivors of testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Study of anxiety disorder and depression in long-term survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Health behaviors and depressive symptoms in testicular cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Chronic cancer-related fatigue in long-term survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Is the sexual function compromised in long-term testicular cancer survivors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Management options for stage I seminoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Management of stage I seminomatous testicular cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Late relapses of germ cell malignancies: incidence, management, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Prospective study of factors predicting adherence to medical advice in men with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Evidence-based guidelines for following stage 1 seminoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Computed Tomography — An Increasing Source of Radiation Exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Comparison of low dose with standard dose abdominal/pelvic multidetector CT in patients with stage 1 testicular cancer under surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

No role for routine chest radiography in stage I seminoma surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Stage II testicular seminoma: patterns of recurrence and outcome of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer--a necessary risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Minimum regions of genomic imbalance in stage I testicular embryonal carcinoma and association of 22q loss with relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Testicular cancer survivorship: research strategies and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Treatment-Associated Leukemia Following Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.11.212

21 January 2018

Identifiers

DOI

10.1586/ERA.11.212

1 reference

26 August 2017

1 reference